PDB Short entry for 3O9L HEADER HYDROLASE/HYDROLASE INHIBITOR 04-AUG-10 3O9L TITLE DESIGN AND OPTIMISATION OF NEW PIPERIDINES AS RENIN INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: UNP RESIDUES 67-232; COMPND 5 SYNONYM: ANGIOTENSINOGENASE; COMPND 6 EC: 3.4.23.15; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: RENIN; COMPND 10 CHAIN: B, D; COMPND 11 FRAGMENT: UNP RESIDUES 237-406; COMPND 12 SYNONYM: ANGIOTENSINOGENASE; COMPND 13 EC: 3.4.23.15; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: REN; SOURCE 13 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS HYDROLASE, PROTEASE, GLYCOSILATION, BLOOD, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR O.CORMINBOEUF,O.BEZENCON,C.GRISOSTOMI,L.REMEN,S.RICHARD-BILDSTEIN, AUTHOR 2 D.BUR,L.PRADE,P.HESS,P.STRICKNER,A.TREIBER REVDAT 3 29-JUL-20 3O9L 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE REVDAT 2 03-AUG-11 3O9L 1 COMPND REVDAT 1 02-MAR-11 3O9L 0 JRNL AUTH O.CORMINBOEUF,O.BEZENCON,C.GRISOSTOMI,L.REMEN, JRNL AUTH 2 S.RICHARD-BILDSTEIN,D.BUR,L.PRADE,P.HESS,P.STRICKNER, JRNL AUTH 3 W.FISCHLI,B.STEINER,A.TREIBER JRNL TITL DESIGN AND OPTIMIZATION OF NEW PIPERIDINES AS RENIN JRNL TITL 2 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 6286 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20843686 JRNL DOI 10.1016/J.BMCL.2010.08.086 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 72.9 REMARK 3 NUMBER OF REFLECTIONS : 20343 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.307 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1083 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1076 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 53.10 REMARK 3 BIN R VALUE (WORKING SET) : 0.2960 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5167 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 102 REMARK 3 SOLVENT ATOMS : 48 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.12000 REMARK 3 B22 (A**2) : 2.00000 REMARK 3 B33 (A**2) : -1.88000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.427 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.322 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 29.136 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.869 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5447 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7402 ; 1.471 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 674 ; 6.863 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 222 ;36.391 ;23.964 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 860 ;18.805 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;15.277 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 820 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4106 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2097 ; 0.228 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3681 ; 0.318 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 157 ; 0.145 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.198 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.144 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3385 ; 1.820 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5388 ; 2.853 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2349 ; 1.708 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2008 ; 2.507 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3O9L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUL-10. REMARK 100 THE DEPOSITION ID IS D_1000060837. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21450 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 49.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 73.6 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.14600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 55.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.31000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-30% PEG 4000 0.6M KCL OR NACL, PH REMARK 280 4.75, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.51550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.38700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.18300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.38700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.51550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.18300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 1 REMARK 465 THR A 2 REMARK 465 LEU A 3 REMARK 465 SER A 166 REMARK 465 HIS B 342 REMARK 465 HIS B 343 REMARK 465 HIS B 344 REMARK 465 HIS B 345 REMARK 465 HIS B 346 REMARK 465 HIS D 342 REMARK 465 HIS D 343 REMARK 465 HIS D 344 REMARK 465 HIS D 345 REMARK 465 HIS D 346 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 17 7.15 55.93 REMARK 500 ASN A 75 -59.38 -134.72 REMARK 500 ALA B 299 45.44 -91.69 REMARK 500 ASN B 332 55.85 38.59 REMARK 500 ASN C 5 22.12 -141.62 REMARK 500 ASN C 75 -70.24 -126.14 REMARK 500 THR C 77 115.31 -28.77 REMARK 500 SER C 84 -76.58 -34.93 REMARK 500 SER D 213 123.17 142.08 REMARK 500 CYS D 217 8.02 59.10 REMARK 500 CYS D 259 23.92 -68.13 REMARK 500 GLU D 288 44.63 -97.05 REMARK 500 SER D 289 160.18 164.84 REMARK 500 ALA D 299 38.25 -83.06 REMARK 500 THR D 312 147.86 173.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3G6Z RELATED DB: PDB REMARK 900 THE SAME PROTEIN AND SIMILAR INHIBITOR REMARK 900 RELATED ID: 3OAG RELATED DB: PDB REMARK 900 RELATED ID: 3OAD RELATED DB: PDB DBREF 3O9L A 1 166 UNP P00797 RENI_HUMAN 67 232 DBREF 3O9L B 171 340 UNP P00797 RENI_HUMAN 237 406 DBREF 3O9L C 1 166 UNP P00797 RENI_HUMAN 67 232 DBREF 3O9L D 171 340 UNP P00797 RENI_HUMAN 237 406 SEQADV 3O9L HIS B 341 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS B 342 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS B 343 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS B 344 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS B 345 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS B 346 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS D 341 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS D 342 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS D 343 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS D 344 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS D 345 UNP P00797 EXPRESSION TAG SEQADV 3O9L HIS D 346 UNP P00797 EXPRESSION TAG SEQRES 1 A 166 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 A 166 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 A 166 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 A 166 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 A 166 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 A 166 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 A 166 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 A 166 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 A 166 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 A 166 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 A 166 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 A 166 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 A 166 VAL PHE SER PHE TYR TYR ASN ARG ASP SER SEQRES 1 B 176 SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO SEQRES 2 B 176 GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE SEQRES 3 B 176 LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER SEQRES 4 B 176 VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU SEQRES 5 B 176 ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SER SEQRES 6 B 176 THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA SEQRES 7 B 176 LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU SEQRES 8 B 176 GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY SEQRES 9 B 176 LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN SEQRES 10 B 176 GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE SEQRES 11 B 176 HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP SEQRES 12 B 176 ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU SEQRES 13 B 176 PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA SEQRES 14 B 176 ARG HIS HIS HIS HIS HIS HIS SEQRES 1 C 166 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 C 166 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 C 166 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 C 166 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 C 166 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 C 166 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 C 166 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 C 166 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 C 166 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 C 166 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 C 166 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 C 166 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 C 166 VAL PHE SER PHE TYR TYR ASN ARG ASP SER SEQRES 1 D 176 SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP PRO SEQRES 2 D 176 GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU ILE SEQRES 3 D 176 LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SER SEQRES 4 D 176 VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS LEU SEQRES 5 D 176 ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SER SEQRES 6 D 176 THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY ALA SEQRES 7 D 176 LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN GLU SEQRES 8 D 176 GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY GLY SEQRES 9 D 176 LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE GLN SEQRES 10 D 176 GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA ILE SEQRES 11 D 176 HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR TRP SEQRES 12 D 176 ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR GLU SEQRES 13 D 176 PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU ALA SEQRES 14 D 176 ARG HIS HIS HIS HIS HIS HIS MODRES 3O9L ASN A 75 ASN GLYCOSYLATION SITE HET NAG A 167 14 HET LPN A 168 44 HET LPN C 167 44 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM LPN (3R,4S)-N-[2-CHLORO-5-(3-METHOXYPROPYL)BENZYL]-N- HETNAM 2 LPN CYCLOPROPYL-4-{4-[2-(2,6-DICHLORO-4-METHYLPHENOXY) HETNAM 3 LPN ETHOXY]PHENYL}PIPERIDINE-3-CARBOXAMIDE FORMUL 5 NAG C8 H15 N O6 FORMUL 6 LPN 2(C35 H41 CL3 N2 O4) FORMUL 8 HOH *48(H2 O) HELIX 1 1 TYR A 55 TYR A 60 1 6 HELIX 2 2 ASP A 65 SER A 69 5 5 HELIX 3 3 PRO A 118 ALA A 122 5 5 HELIX 4 4 PHE A 132 VAL A 140 5 9 HELIX 5 5 PRO A 142 GLY A 151 1 10 HELIX 6 6 ASP B 182 GLN B 184 5 3 HELIX 7 7 SER B 235 GLY B 247 1 13 HELIX 8 8 ASN B 260 GLY B 262 5 3 HELIX 9 9 THR B 280 VAL B 285 1 6 HELIX 10 10 GLY B 316 LYS B 322 1 7 HELIX 11 11 TYR C 55 TYR C 60 1 6 HELIX 12 12 ASP C 65 SER C 69 5 5 HELIX 13 13 PRO C 118 ALA C 122 5 5 HELIX 14 14 PHE C 132 VAL C 140 5 9 HELIX 15 15 PRO C 142 GLN C 150 1 9 HELIX 16 16 SER D 235 GLY D 247 1 13 HELIX 17 17 THR D 280 VAL D 285 1 6 HELIX 18 18 GLY D 316 LYS D 322 1 7 SHEET 1 A 9 LYS A 73 ARG A 82 0 SHEET 2 A 9 THR A 87 VAL A 99 -1 O VAL A 88 N LEU A 81 SHEET 3 A 9 GLN A 19 ILE A 26 -1 N GLY A 25 O THR A 98 SHEET 4 A 9 SER A 8 TYR A 15 -1 N TYR A 15 O GLN A 19 SHEET 5 A 9 GLY B 174 LEU B 178 -1 O LEU B 178 N SER A 8 SHEET 6 A 9 VAL A 157 TYR A 162 -1 N TYR A 161 O GLN B 175 SHEET 7 A 9 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE A 158 SHEET 8 A 9 ARG B 333 ALA B 339 -1 O GLY B 335 N GLU B 326 SHEET 9 A 9 TYR B 186 ASN B 194 -1 N ILE B 193 O ILE B 334 SHEET 1 B13 LYS A 73 ARG A 82 0 SHEET 2 B13 THR A 87 VAL A 99 -1 O VAL A 88 N LEU A 81 SHEET 3 B13 ILE A 102 GLU A 113 -1 O VAL A 104 N ILE A 97 SHEET 4 B13 VAL A 44 PRO A 47 1 N VAL A 44 O GLY A 109 SHEET 5 B13 GLY A 126 GLY A 129 -1 O VAL A 127 N TRP A 45 SHEET 6 B13 GLN A 31 ASP A 38 1 N ASP A 38 O VAL A 128 SHEET 7 B13 GLN A 19 ILE A 26 -1 N ILE A 24 O PHE A 33 SHEET 8 B13 SER A 8 TYR A 15 -1 N TYR A 15 O GLN A 19 SHEET 9 B13 GLY B 174 LEU B 178 -1 O LEU B 178 N SER A 8 SHEET 10 B13 VAL A 157 TYR A 162 -1 N TYR A 161 O GLN B 175 SHEET 11 B13 PHE B 323 ASP B 328 -1 O PHE B 327 N PHE A 158 SHEET 12 B13 ARG B 333 ALA B 339 -1 O GLY B 335 N GLU B 326 SHEET 13 B13 TYR B 186 ASN B 194 -1 N ILE B 193 O ILE B 334 SHEET 1 C 5 GLN B 202 MET B 205 0 SHEET 2 C 5 CYS B 221 VAL B 225 -1 O ALA B 223 N ILE B 203 SHEET 3 C 5 TRP B 313 LEU B 315 1 O TRP B 313 N LEU B 222 SHEET 4 C 5 ILE B 232 GLY B 234 -1 N SER B 233 O ALA B 314 SHEET 5 C 5 ILE B 300 ALA B 302 1 O HIS B 301 N ILE B 232 SHEET 1 D 4 SER B 213 LEU B 216 0 SHEET 2 D 4 VAL B 208 VAL B 210 -1 N VAL B 208 O LEU B 216 SHEET 3 D 4 ILE B 268 LEU B 272 -1 O SER B 269 N SER B 209 SHEET 4 D 4 LYS B 275 LEU B 279 -1 O TYR B 277 N PHE B 270 SHEET 1 E 3 LYS B 249 LYS B 250 0 SHEET 2 E 3 TYR B 255 LYS B 258 -1 O VAL B 256 N LYS B 249 SHEET 3 E 3 LEU B 295 THR B 297 -1 O CYS B 296 N VAL B 257 SHEET 1 F 9 LYS C 73 ARG C 82 0 SHEET 2 F 9 THR C 87 VAL C 99 -1 O GLY C 90 N LEU C 79 SHEET 3 F 9 GLN C 19 ILE C 26 -1 N GLY C 25 O THR C 98 SHEET 4 F 9 SER C 8 TYR C 15 -1 N TYR C 15 O GLN C 19 SHEET 5 F 9 GLY D 174 LEU D 178 -1 O ILE D 176 N VAL C 10 SHEET 6 F 9 VAL C 157 TYR C 162 -1 N SER C 159 O VAL D 177 SHEET 7 F 9 PHE D 323 ASP D 328 -1 O PHE D 327 N PHE C 158 SHEET 8 F 9 ARG D 333 ALA D 339 -1 O ARG D 333 N ASP D 328 SHEET 9 F 9 TYR D 186 ASN D 194 -1 N ILE D 193 O ILE D 334 SHEET 1 G13 LYS C 73 ARG C 82 0 SHEET 2 G13 THR C 87 VAL C 99 -1 O GLY C 90 N LEU C 79 SHEET 3 G13 ILE C 102 GLU C 113 -1 O GLU C 110 N PHE C 91 SHEET 4 G13 VAL C 44 PRO C 47 1 N VAL C 44 O GLY C 109 SHEET 5 G13 GLY C 126 GLY C 129 -1 O VAL C 127 N TRP C 45 SHEET 6 G13 GLN C 31 ASP C 38 1 N VAL C 36 O VAL C 128 SHEET 7 G13 GLN C 19 ILE C 26 -1 N GLY C 22 O VAL C 35 SHEET 8 G13 SER C 8 TYR C 15 -1 N TYR C 15 O GLN C 19 SHEET 9 G13 GLY D 174 LEU D 178 -1 O ILE D 176 N VAL C 10 SHEET 10 G13 VAL C 157 TYR C 162 -1 N SER C 159 O VAL D 177 SHEET 11 G13 PHE D 323 ASP D 328 -1 O PHE D 327 N PHE C 158 SHEET 12 G13 ARG D 333 ALA D 339 -1 O ARG D 333 N ASP D 328 SHEET 13 G13 TYR D 186 ASN D 194 -1 N ILE D 193 O ILE D 334 SHEET 1 H 5 GLN D 202 MET D 205 0 SHEET 2 H 5 CYS D 221 VAL D 225 -1 O ALA D 223 N ILE D 203 SHEET 3 H 5 TRP D 313 LEU D 315 1 O LEU D 315 N LEU D 224 SHEET 4 H 5 ILE D 232 GLY D 234 -1 N SER D 233 O ALA D 314 SHEET 5 H 5 ILE D 300 ALA D 302 1 O HIS D 301 N ILE D 232 SHEET 1 I 4 THR D 214 LEU D 216 0 SHEET 2 I 4 VAL D 208 VAL D 210 -1 N VAL D 208 O LEU D 216 SHEET 3 I 4 ILE D 268 PHE D 270 -1 O SER D 269 N SER D 209 SHEET 4 I 4 TYR D 277 LEU D 279 -1 O TYR D 277 N PHE D 270 SHEET 1 J 3 LYS D 249 LYS D 250 0 SHEET 2 J 3 TYR D 255 LYS D 258 -1 O VAL D 256 N LYS D 249 SHEET 3 J 3 LEU D 295 THR D 297 -1 O CYS D 296 N VAL D 257 SSBOND 1 CYS A 51 CYS A 58 1555 1555 2.03 SSBOND 2 CYS B 217 CYS B 221 1555 1555 2.04 SSBOND 3 CYS B 259 CYS B 296 1555 1555 2.07 SSBOND 4 CYS C 51 CYS C 58 1555 1555 2.05 SSBOND 5 CYS D 217 CYS D 221 1555 1555 2.03 SSBOND 6 CYS D 259 CYS D 296 1555 1555 2.04 LINK ND2 ASN A 75 C1 NAG A 167 1555 1555 1.45 CISPEP 1 THR A 28 PRO A 29 0 -16.35 CISPEP 2 LEU A 117 PRO A 118 0 1.81 CISPEP 3 PRO B 307 PRO B 308 0 1.27 CISPEP 4 GLY B 310 PRO B 311 0 -2.08 CISPEP 5 THR C 28 PRO C 29 0 -2.64 CISPEP 6 LEU C 117 PRO C 118 0 6.79 CISPEP 7 PRO D 307 PRO D 308 0 0.41 CISPEP 8 GLY D 310 PRO D 311 0 -8.46 CRYST1 67.031 90.366 120.774 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014918 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011066 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008280 0.00000